Serum magnesium and end-stage renal diseaseHUTCHISON, A. J.Peritoneal dialysis international. 1997, Vol 17, Num 4, pp 327-329, issn 0896-8608Article

Peritoneal dialysis fluids for the future : do we have the solution ?HUTCHISON, A. J; GOKAL, R.Dialysis & transplantation. 1992, Vol 21, Num 2, pp 57-63, issn 0090-2934, 108 [6 p.]Article

Towards tailored dialysis fluids in CAPD―the role of reduced calcium and magnesium in dialysis fluidsHUTCHISON, A. J; RAM GOKAL.Peritoneal dialysis international. 1992, Vol 12, Num 2, pp 199-203, issn 0896-8608Article

Substituted chromenes as potent, orally active 5-lipoxygenase inhibitorsSATOH, Y; STANTON, J. L; HUTCHISON, A. J et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 23, pp 3580-3594, issn 0022-2623Article

The effect of hemoglobin concentration on peritoneal mass transfer and drain volumes in continuous ambulatory peritoneal dialysisHUTCHISON, A. J; OFSTHUN, N. J; HOWARTH, D et al.Peritoneal dialysis international. 1992, Vol 12, Num 2, pp 230-233, issn 0896-8608Article

High selective adenosine A₂ receptor agonsits in a series of N-alkylated 2-aminoadenosinesFRANCIS, J. E; WEBB, R. L; BARCLAY, B et al.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 8, pp 2570-2579, issn 0022-2623Article

[³H]CGS 21680, a selective A₂ adenosine receptor agonist directly labels A₂ receptors in rat brainJARVIS, M. F; SCHULZ, R; HUTCHISON, A. J et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 251, Num 3, pp 888-893, issn 0022-3565Article

High-frequency signal processing using magnetic layered structuresCAMLEY, R. E; CELINSKI, Z; FAL, T et al.Journal of magnetism and magnetic materials. 2009, Vol 321, Num 14, pp 2048-2054, issn 0304-8853, 7 p.Article

Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease Stage 5 receiving hemodialysisHUTCHISON, A. J; BARNETT, M. E; KRAUSE, R et al.Clinical nephrology. 2009, Vol 71, Num 3, pp 286-295, issn 0301-0430, 10 p.Article

Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluidHUTCHISON, A. J; MERCHANT, M; BOULTON, H. F et al.Peritoneal dialysis international. 1993, Vol 13, Num 3, pp 219-223, issn 0896-8608Article

Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptorsBENNETT, D. A; BERNARD, P. S; AMRICK, C. L et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 250, Num 2, pp 454-460, issn 0022-3565Article

Adequacy of calcium and phosphate balance in peritoneal dialysisHUTCHISON, A. J; GOKAL, R.Peritoneal dialysis international. 1994, Vol 14, pp S117-S122, issn 0896-8608, SUP3Conference Paper

Effect of long-term therapy with 1.25 mmol/L calcium peritoneal dialysis fluid on the incidence of peritonitis in CAPDHUTCHISON, A. J; TURNER, K; RAM GOKAL et al.Peritoneal dialysis international. 1992, Vol 12, Num 3, pp 321-323, issn 0896-8608Article

Macroglossia and amyloidoma of the buttock : evidence of systemic involvement in dialysis amyloidSETHI, D; HUTCHISON, A. J; CARY, N. R. B et al.Nephron. 1990, Vol 55, Num 3, pp 312-315, issn 0028-2766, 4 p.Article

CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonistLEHMANN, J; HUTCHISON, A. J; CHENEY, D. L et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 1, pp 65-75, issn 0022-3565Article

Side-effects of antituberculosis drug treatment in patients with chronic renal failureQUANTRILL, S. J; WOODHEAD, M. A; BELL, C. E et al.The European respiratory journal. 2002, Vol 20, Num 2, pp 440-443, issn 0903-1936Article

Effect of 1,25-dihydroxyvitamin D₃ and calcium carbonate on bone loss associated with long-term renal transplantationCUETO-MANZANO, A. M; KONEL, S; FREEMONT, A. J et al.American journal of kidney diseases. 2000, Vol 35, Num 2, pp 227-236, issn 0272-6386Article

Low turnover bone diseaseHUTCHISON, A. J; MOORE, P. R.Peritoneal dialysis international. 1996, Vol 16, pp S295-S299, issn 0896-8608, SUP1Conference Paper

Peritoneal dialysate IgG/C3 levels do not predict susceptibility to peritonitisANWAR, N; HUTCHISON, A. J; MANOS, J et al.Peritoneal dialysis international. 1996, Vol 16, Num 2, pp 154-157, issn 0896-8608Conference Paper

Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemiaHUTCHISON, A. J; FREEMONT, A. J; BOULTON, H. F et al.Nephrology, dialysis, transplantation (Print). 1992, Vol 7, Num 12, pp 1219-1225, issn 0931-0509Article

The adenosine/neutrophil paradox resolved : human neutrophils possess both A ₁ and A₂ receptors that promote chemotaxis and inhibit O₂^- generation, respectivelyCRONSTEIN, B. N; DAGUMA, L; NICHOLS, D et al.The Journal of clinical investigation. 1990, Vol 85, Num 4, pp 1150-1157, issn 0021-9738Article

Characterization of the binding of [³H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brainMURPHY, D. E; HUTCHISON, A. J; HURT, S. D et al.British journal of pharmacology. 1988, Vol 95, Num 3, pp 932-938, issn 0007-1188Article